Metformin may function as anti-cancer agent via targeting cancer stem cells: the potential biological significance of tumor-associated miRNAs in breast and pancreatic cancers

Metformin may function as anti-cancer agent via targeting cancer stem cells: the potential biological significance of tumor-associated miRNAs in breast and pancreatic cancers

Item
http://www.wikidata.org/entity/Q34357952
Somatostatin Analogs Treated Small Intestinal Neuroendocrine Tumor Patients Circulating MicroRNAs.Contribution of microRNAs in understanding the pancreatic tumor microenvironment involving cancer associated stellate and fibroblast cells.MicroRNA-144 regulates proliferation, invasion, and apoptosis of cells in malignant solitary pulmonary nodule via zinc finger E-box-binding homeobox 1.MiR-300 regulate the malignancy of breast cancer by targeting p53.Prognostic value of clinicopathological characteristics in patients with pancreatic cancer5-fluorouracil resistant colon cancer cells are addicted to OXPHOS to survive and enhance stem-like traits.A novel method to limit breast cancer stem cells in states of quiescence, proliferation or differentiation: Use of gel stress in combination with stem cell growth factorsProliferation and metastatic potential of endometrial cancer cells in response to metformin treatment in a high versus normal glucose environment.Metformin, an old drug, brings a new era to cancer therapyNovel Holistic Approaches for Overcoming Therapy Resistance in Pancreatic and Colon Cancers.Synergistic cell death in FLT3-ITD positive acute myeloid leukemia by combined treatment with metformin and 6-benzylthioinosine.Metformin Prevents Renal Fibrosis in Mice with Unilateral Ureteral Obstruction and Inhibits Ang II-Induced ECM Production in Renal Fibroblasts.Metformin induces apoptosis of human hepatocellular carcinoma HepG2 cells by activating an AMPK/p53/miR-23a/FOXA1 pathway.Diabetes medication associates with DNA methylation of metformin transporter genes in the human liver.New metformin derivative HL156A prevents oral cancer progression by inhibiting the insulin-like growth factor/AKT/mammalian target of rapamycin pathways.Targeting Pancreatic Cancer Cell Plasticity: The Latest in Therapeutics.Metformin Regulating miR-34a Pathway to Inhibit Egr1 in Rat Mesangial Cells Cultured with High Glucose.
P2860

Metformin may function as anti-cancer agent via targeting cancer stem cells: the potential biological significance of tumor-associated miRNAs in breast and pancreatic cancers

Item
http://www.wikidata.org/entity/Q34357952
description
2014 nî lūn-bûn
@nan
2014 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Metformin may function as anti ...... breast and pancreatic cancers
@ast
Metformin may function as anti ...... breast and pancreatic cancers
@en
Metformin may function as anti ...... breast and pancreatic cancers
@nl
type
label
Metformin may function as anti ...... breast and pancreatic cancers
@ast
Metformin may function as anti ...... breast and pancreatic cancers
@en
Metformin may function as anti ...... breast and pancreatic cancers
@nl
prefLabel
Metformin may function as anti ...... breast and pancreatic cancers
@ast
Metformin may function as anti ...... breast and pancreatic cancers
@en
Metformin may function as anti ...... breast and pancreatic cancers
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P5875
P698
P921
P932
P356
P1433
P1476
Metformin may function as anti ...... breast and pancreatic cancers
@en
P2093
P2860
P304
P31
P356
10.3978/J.ISSN.2305-5839.2014.06.05
P433
P478
P50
P577
P5875
P698
P921
P932